Loss of IGF2 imprinting has also been observed in UCS tumor tissue 13, and nonislet cell hypoglycemia due to tumor production of incompletely processed forms of pro‐IGF2 (“big” IGF2) was previously reported in patients with UCS 14, supporting a potential, unrecognized role of IGF2 in UCS. Here, IGF2 is linked to neoplasm.